Dna X (SONM) Short-term Investments (2018 - 2025)

Dna X has reported Short-term Investments for 7 years, with the latest figure at $2.2 million in Q3 2025.

• For the quarter ending Q3 2025, Short-term Investments changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2025 stood at $2.2 million (changed N/A YoY), and the FY2024 full-year result was $2.7 million, up 1269.04% from the prior year.
• Short-term Investments for Q3 2025 stood at $2.2 million, down from $3.4 million in the prior quarter.
• The five-year high for Short-term Investments was $3.4 million in Q2 2025, with the low at $197000.0 in Q4 2023.
• Historically, Short-term Investments has averaged $2.1 million across 4 years, with a median of $2.4 million in 2024.
• Annual changes were most pronounced in 2021 — Short-term Investments dropped 8.12% — and 2024, when it soared 1269.04%.
• Dna X's Short-term Investments stood at $1.0 million in 2021, then plunged by 81.08% to $197000.0 in 2023, then soared by 1269.04% to $2.7 million in 2024, then retreated by 18.95% to $2.2 million in 2025.
• The last three Short-term Investments figures came in at $2.2 million (Q3 2025), $3.4 million (Q2 2025), and $2.8 million (Q1 2025), per Business Quant data.